Drug: alpha-1-proteinase inhibitor, human, 1000MG, vial, INJ (prolastin C-approx 1000MG/vial)
Ended Awarded Last action
- Contract number
- VA26017J1565
- Awardee
-
Grifols Therapeutics LLC UEI UFQ3A7GKJ5C7
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $266,507
Award facts
- Contract value 100% obligated
- $266,507.04 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Portland, OR 97239, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $5,357 | |
| Supplemental Agreement for work within scope | $21,151 | |
| Original award | $240,000 |
About this award
This is a $266,507.04 federal contract award from the Department of Veterans Affairs (VA) to Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals. The contract is a Blanket Purchase Agreement (BPA) call order under the VA's Pharmaceuticals and Drugs GSA Schedule, and is for the delivery of 1,000mg vials of the drug Alpha-1-Proteinase Inhibitor, Human (Prolastin C). The contract has an ultimate completion date of October 26, 2017 and does not utilize any small business set-asides. Grifols has previously provided pharmaceutical products to the VA and the Defense Logistics Agency through various contract vehicles.
Quick answers
Who was awarded contract VA26017J1565?
VA26017J1565 was awarded to Grifols Therapeutics LLC by Veterans Integrated Service Network 20 (Veterans Health Administration) on October 1, 2016.
How much is contract VA26017J1565 worth?
The government has obligated $266,507 on VA26017J1565.
Is contract VA26017J1565 an order under another contract?
Yes. VA26017J1565 is a BPA call under V797D30042-VA797P13A0002, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract VA26017J1565 competed?
The extent of competition for VA26017J1565 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award